Today's Daily Dose brings you news about AnaptysBio's (ANAB) trial results of Etokimab in adult patients with severe eosinophilic asthma; near-term catalyst of Audentes Therapeutics; lifting of partial clinical hold that was slapped on Epizyme's Tazemetostat clinical trials; workforce reduction in Gemphire and FDA approval of Verastem's COPIKTRA.
from RTT - Biotech https://ift.tt/2OOvGXq
via IFTTT
No comments:
Post a Comment